Need for optimisation of immuniastion strategeis targeting Invasive Meningococcal Disease in the netherlands

Autor: Joost Ruitenberg, Josefien Cornelie Minthe Bousema
Přispěvatelé: Science and Society, Athena Institute
Jazyk: angličtina
Rok vydání: 2015
Předmět:
Pediatrics
medicine.medical_specialty
Health (social science)
Adolescent
Leadership and Management
Population
Immunization
Secondary
Meningococcal Vaccines
Booster dose
Meningococcal vaccine
Disease
Neisseria meningitidis
Management
Monitoring
Policy and Law
Serogroup
National Immunisation Programme (NIP)
Health Information Management
SDG 3 - Good Health and Well-being
Conjugate vaccine
medicine
Humans
Child
Intensive care medicine
education
Netherlands
Health Services Needs and Demand
education.field_of_study
Vaccines
Vaccines
Conjugate
Immunization Programs
business.industry
Health Policy
Public health
Prevention
lcsh:Public aspects of medicine
Vaccination
Infant
lcsh:RA1-1270
Invasive Meningococcal Disease (IMD)
Policy Brief
Meningococcal Infections
Immunisation
Infectious disease (medical specialty)
Public Health
business
Zdroj: Bousema, J C M & Ruitenberg, E J 2015, ' Need for optimisation of immuniastion strategeis targeting Invasive Meningococcal Disease in the netherlands ', International Journal of Health Policy and Management, vol. 4, no. 11, pp. 757-776 . https://doi.org/10.15171/ijhpm.2015.168
International Journal of Health Policy and Management, Vol 4, Iss 11, Pp 757-761 (2015)
International Journal of Health Policy and Management, 4(11), 757-776. Kerman University of Medical Sciences
ISSN: 2322-5939
Popis: Invasive meningococcal disease (IMD) is a severe bacterial infectious disease with high mortality and morbidity rates worldwide. In recent years, industrialised countries have implemented vaccines targeting IMD in their National Immunisation Programmes (NIPs). In 2002, the Netherlands successfully implemented a single dose of meningococcal serogroup C conjugate vaccine at the age of 14 months and performed a single catch-up for children ≤18 years of age. Since then the disease disappeared in vaccinated individuals. Furthermore, herd protection was induced, leading to a significant IMD reduction in non-vaccinated individuals. However, previous studies revealed that the current programmatic immunisation strategy was insufficient to protect the population in the foreseeable future. In addition, vaccines that provide protection against additional serogroups are now available. This paper describes to what extent the current strategy to prevent IMD in the Netherlands is still sufficient, taking into account the burden of disease and the latest scientific knowledge related to IMD and its prevention. In particular, primary MenC immunisation seems not to provide long-term protection, indicating a risk for possible recurrence of the disease. This can be combatted by implementing a MenC or MenACWY adolescent booster vaccine. Additional health benefits can be achieved by replacing the primary MenC by a MenACWY vaccine. By implementation of a recently licensed MenB vaccine for infants in the NIP, the greatest burden of disease would be targeted. This paper shows that optimisation of the immunisation strategy targeting IMD in the Netherlands should be considered and contributes to create awareness concerning prevention optimisation in other countries.
Databáze: OpenAIRE
Externí odkaz: